Diabetes mellitus
Conditions
Interventions
Glucose monitoring by FGM for 14 days will be performed every 5 weeks for a total of 3 times.During the post-monitoring visits, guidance will be given and medications will be changed as needed at the
Sponsors
Niigata University Faculty of Medicine Department of Internal Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Those with diabetes mellitus 2. Patients on insulin medication 3. Patients who can use the smartphone application "Think Health" (H2 Co., Ltd.) 4. Patients who are between 20 and 80 years old at the time of consent. 5. HbA1c 7.0% or higher, but less than 10.0%. 6.Patients with a BMI of more than 15 kg/m2 or less than 30 kg/m2. 7.Patients who have given written consent to participate in the study
Exclusion criteria
Exclusion criteria: 1. Patients with food intake (excluding snacks) other than three times a day 2. Patients with anorexia nervosa 3. Patients with alcohol overdose 4. Patients who are deemed inappropriate by the physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| After obtaining consent, 40 diabetic patients who require lifestyle improvement for blood glucose control will be assigned to 1) FGM alone (FGM alone group) or 2) FGM plus lifestyle monitoring (FGM plus lifestyle monitoring group). The degree of improvement in blood glucose control (Time In Range = percentage of target blood glucose of 70 mg/dl-180 mg/dl measured by FGM) after 3 months will be compared. | — |
Countries
Japan
Contacts
Public ContactMasaru Kitazawa
Niigata University Faculty of Medicine Department of Internal Medicine Department of Community Medicine and Health
Outcome results
None listed